No Data
No Data
Medicare (688079.SH): The company successfully developed the TGV process
Gelonghui, May 22丨Mediq (688079.SH) said on the investor interactive platform that the company has successfully developed the TGV process (glass through-hole process) to treat glass substrates with tiny holes (min10μm) through holes and blind holes through laser-induced and wet corrosion processes.
Medicare (688079.SH): Repurchase 406,400 shares as of April 30
Gelonghui (688079.SH) announced on May 6, 2024, that as of April 30, 2024, the company had repurchased 406,392 shares of the company through centralized bidding transactions, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest price of the repurchase transaction was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96 (excluding transaction fees such as stamp duty and transaction fees).
Medicai (688079.SH): Net loss of 235.59 million yuan in the first quarter
On April 28, Ge Longhui (688079.SH) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 116 million yuan, an increase of 22.30% over the previous year. Achieved a net loss of 235.59 million yuan attributable to shareholders of listed companies. Achieved a net loss of RMB 18.0883 million attributable to shareholders of the listed company after deducting non-recurring profit and loss.
Medicare (688079.SH) reported 2023 results, with a net loss of 84.4509 million yuan, which changed from profit to loss over the previous year
Medicare (688079.SH) released its 2023 annual report, achieving operating revenue of 321 million yuan, compared with...
Medicare (688079.SH): First quarter report will be disclosed on April 29th
On April 15, GLONGHUI (688079.SH) said on the investor interactive platform that according to the work schedule, the company's report for the first quarter of 2024 will be disclosed on April 29, 2024.
Medicare (688079.SH): Repurchase 406,400 shares as of March 31
Gelonghui, April 2, 丨 Medicai (688079.SH) announced that as of March 31, 2024, the company had repurchased 406,392.00 shares of the company through centralized bidding transactions, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest price of the repurchase transaction was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96 (excluding transaction fees such as stamp duty and transaction fees).
No Data